FOLLITROPIN

FOLLITROPIN was reported 2046 times

These side effects are most commonly reported by patients taking FOLLITROPIN:

# Side effect Count
0 NO ADVERSE EVENT 176
1 HEADACHE 120
2 POOR QUALITY DEVICE USED 91
3 ABDOMINAL DISTENSION 80
4 PRODUCT PACKAGING QUANTITY ISSUE 74
5 PRODUCT QUALITY ISSUE 69
6 FATIGUE 67
7 INCORRECT DOSE ADMINISTERED 67
8 INJECTION SITE PAIN 63
9 NAUSEA 61
10 PRODUCT DOSE OMISSION ISSUE 54
11 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 51
12 DEVICE MALFUNCTION 43
13 OVARIAN HYPERSTIMULATION SYNDROME 43
14 MATERNAL EXPOSURE DURING PREGNANCY 32
15 RASH 32
16 PRURITUS 31
17 INJECTION SITE REACTION 29
18 INJECTION SITE BRUISING 27
19 INJECTION SITE ERYTHEMA 27
20 DEVICE LEAKAGE 26
21 HOT FLUSH 26
22 DRUG INEFFECTIVE 25
23 DIZZINESS 24
24 INJECTION SITE PRURITUS 24
25 INCORRECT DOSE ADMINISTERED BY DEVICE 23
26 PAIN 23
27 MATERNAL EXPOSURE BEFORE PREGNANCY 21
28 PRODUCT STORAGE ERROR 21
29 DIARRHOEA 19
30 VOMITING 19
31 ABORTION SPONTANEOUS 17
32 CONSTIPATION 17
33 MUSCLE SPASMS 17
34 URTICARIA 17
35 NEEDLE ISSUE 16
36 POOR QUALITY PRODUCT ADMINISTERED 15
37 DRUG DOSE OMISSION 14
38 PRODUCT DOSE OMISSION 14
39 PRODUCT USE IN UNAPPROVED INDICATION 14
40 DEVICE BREAKAGE 13
41 DEVICE ISSUE 13
42 EXPOSURE DURING PREGNANCY 13
43 CONTUSION 12
44 DEVICE DIFFICULT TO USE 12
45 DEVICE DEFECTIVE 11
46 DYSPNOEA 11
47 INJECTION SITE RASH 11
48 MIGRAINE 11
49 WEIGHT INCREASED 11
50 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11
51 ADVERSE EVENT 10
52 INJECTION SITE MASS 10
53 ABDOMINAL DISCOMFORT 9
54 ABDOMINAL PAIN 9
55 ABDOMINAL PAIN UPPER 9
56 ACCIDENTAL EXPOSURE TO PRODUCT 9
57 INJECTION SITE SWELLING 9
58 OFF LABEL USE 9
59 VAGINAL HAEMORRHAGE 9
60 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9
61 FEELING ABNORMAL 8
62 MOOD SWINGS 8
63 PRODUCT PACKAGING ISSUE 8
64 SWELLING 8
65 HYPERSENSITIVITY 7
66 PRODUCT LEAKAGE 7
67 BURNING SENSATION 6
68 ECTOPIC PREGNANCY 6
69 ERYTHEMA 6
70 FOETAL EXPOSURE DURING PREGNANCY 6
71 INJECTION SITE IRRITATION 6
72 PRODUCT USE ISSUE 6
73 PYREXIA 6
74 RASH ERYTHEMATOUS 6
75 SOMNOLENCE 6
76 ANXIETY 5
77 ASTHENIA 5
78 CHEST PAIN 5
79 COUGH 5
80 COVID-19 5
81 DRUG INTERACTION 5
82 EXPOSURE VIA SKIN CONTACT 5
83 INJECTION SITE URTICARIA 5
84 INSOMNIA 5
85 IRRITABILITY 5
86 LIP SWELLING 5
87 MALAISE 5
88 MOOD ALTERED 5
89 OVARIAN DISORDER 5
90 PARAESTHESIA 5
91 PERIPHERAL SWELLING 5
92 PRODUCT AVAILABILITY ISSUE 5
93 PRODUCT PRESCRIBING ISSUE 5
94 STRESS 5
95 TACHYCARDIA 5
96 VISION BLURRED 5
97 ARNOLD-CHIARI MALFORMATION 4
98 BREAST TENDERNESS 4
99 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 4
100 DECREASED APPETITE 4
101 DISCOMFORT 4
102 DRUG DOSE OMISSION BY DEVICE 4
103 DRUG HYPERSENSITIVITY 4
104 EMOTIONAL DISORDER 4
105 HYPERTHYROIDISM 4
106 HYPOAESTHESIA 4
107 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
108 PALPITATIONS 4
109 PREGNANCY 4
110 PRODUCT DELIVERY MECHANISM ISSUE 4
111 SPINA BIFIDA 4
112 UNDERDOSE 4
113 ACCIDENTAL OVERDOSE 3
114 ADVERSE REACTION 3
115 ALOPECIA 3
116 APPLICATION SITE PRURITUS 3
117 ARTHRALGIA 3
118 BACK PAIN 3
119 BREAST DISCHARGE 3
120 BREAST PAIN 3
121 CHEST DISCOMFORT 3
122 CHILLS 3
123 CRYING 3
124 CYST 3
125 DEEP VEIN THROMBOSIS 3
126 DRY SKIN 3
127 DYSPEPSIA 3
128 FALL 3
129 FEELING HOT 3
130 FLUSHING 3
131 HYPERCOAGULATION 3
132 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3
133 INJECTION SITE DISCOMFORT 3
134 INJURY ASSOCIATED WITH DEVICE 3
135 LIQUID PRODUCT PHYSICAL ISSUE 3
136 MENSTRUAL DISORDER 3
137 MYALGIA 3
138 OPTIC NERVE SHEATH MENINGIOMA 3
139 OVARIAN CYST 3
140 OVERDOSE 3
141 PRODUCT ADMINISTRATION ERROR 3
142 PRODUCT DOSE OMISSION IN ERROR 3
143 RASH PRURITIC 3
144 SWELLING FACE 3
145 THERAPY CESSATION 3
146 THROMBOSIS 3
147 THYROID DISORDER 3
148 WHITE BLOOD CELL COUNT DECREASED 3
149 ABNORMAL DREAMS 2
150 ACNE 2
151 ADVERSE DRUG REACTION 2
152 ANAPHYLACTIC REACTION 2
153 ANGER 2
154 APPLICATION SITE ERYTHEMA 2
155 ASCITES 2
156 BLINDNESS TRANSIENT 2
157 BLOOD LUTEINISING HORMONE INCREASED 2
158 BREAST SWELLING 2
159 CAESAREAN SECTION 2
160 CARDIAC DISORDER 2
161 CHOLELITHIASIS 2
162 CONFUSIONAL STATE 2
163 CONGENITAL CHOROID PLEXUS CYST 2
164 CONTRAINDICATED PRODUCT ADMINISTERED 2
165 DEHYDRATION 2
166 DEPRESSION 2
167 DERMATITIS ALLERGIC 2
168 DERMATITIS ATOPIC 2
169 DEVICE USE ISSUE 2
170 DRUG EXPOSURE BEFORE PREGNANCY 2
171 ENDOMETRIOSIS 2
172 EXPIRED DEVICE USED 2
173 EXPIRED DRUG ADMINISTERED 2
174 FEAR 2
175 FLUID RETENTION 2
176 FOETAL GROWTH RESTRICTION 2
177 FUNGAL INFECTION 2
178 GASTRITIS 2
179 HAEMORRHAGIC OVARIAN CYST 2
180 HAIR GROWTH ABNORMAL 2
181 HEART RATE INCREASED 2
182 HUMAN CHORIONIC GONADOTROPIN INCREASED 2
183 HYPOACUSIS 2
184 HYPOAESTHESIA ORAL 2
185 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
186 INJECTION SITE DISCOLOURATION 2
187 INJECTION SITE HAEMORRHAGE 2
188 INJECTION SITE HYPERSENSITIVITY 2
189 INJECTION SITE WARMTH 2
190 LIMB INJURY 2
191 MATERNAL DRUGS AFFECTING FOETUS 2
192 MATERNAL EXPOSURE TIMING UNSPECIFIED 2
193 MUSCULAR WEAKNESS 2
194 NECK PAIN 2
195 NEPHROLITHIASIS 2
196 NIGHT SWEATS 2
197 NIPPLE DISORDER 2
198 NIPPLE PAIN 2
199 NORMAL NEWBORN 2
200 OCCUPATIONAL EXPOSURE TO PRODUCT 2
201 PLEURAL EFFUSION 2
202 PNEUMONIA 2
203 POLYP 2
204 POOR QUALITY SLEEP 2
205 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2
206 PRODUCT CONTAINER ISSUE 2
207 PRODUCT CONTAMINATION PHYSICAL 2
208 PRODUCT DISPENSING ERROR 2
209 PRODUCT DISPENSING ISSUE 2
210 PRODUCT LABEL ISSUE 2
211 PRODUCT SUPPLY ISSUE 2
212 PSORIASIS 2
213 PULMONARY EMBOLISM 2
214 RHEUMATOID ARTHRITIS 2
215 RUPTURED ECTOPIC PREGNANCY 2
216 SINUSITIS 2
217 SKIN BURNING SENSATION 2
218 SKIN IRRITATION 2
219 SWOLLEN TONGUE 2
220 SYNCOPE 2
221 THERAPEUTIC RESPONSE DECREASED 2
222 THERAPY INTERRUPTED 2
223 THROAT TIGHTNESS 2
224 TINEA VERSICOLOUR 2
225 TREMOR 2
226 TWIN PREGNANCY 2
227 UTERINE LEIOMYOMA 2
228 VAGINAL DISCHARGE 2
229 VULVOVAGINAL DISCOMFORT 2
230 WRONG PRODUCT ADMINISTERED 2
231 ABDOMINAL PAIN LOWER 1
232 ABORTION THREATENED 1
233 ABSCESS DRAINAGE 1
234 ADHESION 1
235 ADNEXA UTERI PAIN 1
236 ADVERSE FOOD REACTION 1
237 AFFECTIVE DISORDER 1
238 AGITATION 1
239 ALANINE AMINOTRANSFERASE INCREASED 1
240 ANAEMIA MACROCYTIC 1
241 ANENCEPHALY 1
242 ANOVULATORY CYCLE 1
243 APPLICATION SITE NODULE 1
244 APPLICATION SITE SWELLING 1
245 ASPARTATE AMINOTRANSFERASE INCREASED 1
246 ASSISTED FERTILISATION 1
247 ASTHMA 1
248 AUTOIMMUNE THYROIDITIS 1
249 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
250 BACTERIAL VAGINOSIS 1
251 BIOCHEMICAL PREGNANCY 1
252 BLEPHAROSPASM 1
253 BLINDNESS UNILATERAL 1
254 BLISTER 1
255 BLOOD ALBUMIN DECREASED 1
256 BLOOD ALKALINE PHOSPHATASE INCREASED 1
257 BLOOD BILIRUBIN INCREASED 1
258 BLOOD CHLORIDE INCREASED 1
259 BLOOD DISORDER 1
260 BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED 1
261 BLOOD HUMAN CHORIONIC GONADOTROPIN NEGATIVE 1
262 BLOOD OESTROGEN INCREASED 1
263 BLOOD POTASSIUM INCREASED 1
264 BLOOD SODIUM DECREASED 1
265 BLOOD UREA INCREASED 1
266 BLOOD VISCOSITY ABNORMAL 1
267 BONE DISORDER 1
268 BRADYPHRENIA 1
269 BRAIN FOG 1
270 CALCIUM DEFICIENCY 1
271 CAROTID ARTERY THROMBOSIS 1
272 CEREBRAL DISORDER 1
273 CEREBRAL INFARCTION 1
274 CEREBRAL ISCHAEMIA 1
275 CEREBROVASCULAR ACCIDENT 1
276 CHAPPED LIPS 1
277 CHEILITIS 1
278 CHOLECYSTITIS 1
279 CHOROIDAL NEOVASCULARISATION 1
280 COGNITIVE DISORDER 1
281 CONDITION AGGRAVATED 1
282 DEPRESSED MOOD 1
283 DEVICE DELIVERY SYSTEM ISSUE 1
284 DEVICE DEPLOYMENT ISSUE 1
285 DEVICE DISPENSING ERROR 1
286 DEVICE EXPULSION 1
287 DEVICE MATERIAL ISSUE 1
288 DEVICE OPERATIONAL ISSUE 1
289 DEVICE PHYSICAL PROPERTY ISSUE 1
290 DEVICE USE CONFUSION 1
291 DISEASE PROGRESSION 1
292 DISSEMINATED INTRAVASCULAR COAGULATION 1
293 DRAINAGE 1
294 DRUG EFFECT DECREASED 1
295 DRUG EFFECT LESS THAN EXPECTED 1
296 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
297 DRUG EXPOSURE DURING PREGNANCY 1
298 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
299 DRY EYE 1
300 DYSGEUSIA 1
301 DYSMENORRHOEA 1
302 DYSURIA 1
303 EAR CONGESTION 1
304 EAR DISCOMFORT 1
305 EAR PAIN 1
306 EAR SWELLING 1
307 ECTOPIC PREGNANCY TERMINATION 1
308 ECZEMA 1
309 EFFUSION 1
310 EMBOLISM 1
311 EMERGENCY CARE 1
312 EMOTIONAL DISTRESS 1
313 ENDOMETRIAL HYPERTROPHY 1
314 ENTEROBACTER SEPSIS 1
315 EXPIRED PRODUCT ADMINISTERED 1
316 EXPOSURE TO CONTAMINATED DEVICE 1
317 EXPOSURE VIA DIRECT CONTACT 1
318 EYE IRRITATION 1
319 EYE OEDEMA 1
320 EYE PRURITUS 1
321 EYE SWELLING 1
322 FAILED IN VITRO FERTILISATION 1
323 FEELING JITTERY 1
324 FLATULENCE 1
325 GAIT DISTURBANCE 1
326 GAIT INABILITY 1
327 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
328 GASTROINTESTINAL ANGIODYSPLASIA 1
329 GASTROINTESTINAL MUCOSAL DISORDER 1
330 GENERAL PHYSICAL HEALTH DETERIORATION 1
331 GINGIVAL BLEEDING 1
332 HAEMARTHROSIS 1
333 HAEMATOCRIT INCREASED 1
334 HAEMOGLOBIN DECREASED 1
335 HAEMOGLOBIN INCREASED 1
336 HAEMORRHAGE 1
337 HAEMORRHAGIC TRANSFORMATION STROKE 1
338 HALLUCINATION 1
339 HEMIANOPIA HOMONYMOUS 1
340 HEPATIC ENZYME INCREASED 1
341 HIATUS HERNIA 1
342 HIDRADENITIS 1
343 HOSPITALISATION 1
344 HYPERHIDROSIS 1
345 HYPERTENSION 1
346 HYPERTRANSAMINASAEMIA 1
347 HYPOTENSION 1
348 HYPOTHYROIDISM 1
349 ILL-DEFINED DISORDER 1
350 ILLNESS 1
351 IN VITRO FERTILISATION 1
352 INCORRECT DOSAGE ADMINISTERED 1
353 INCORRECT DOSE ADMINISTERED BY PRODUCT 1
354 INCORRECT DRUG ADMINISTRATION DURATION 1
355 INCORRECT DRUG ADMINISTRATION RATE 1
356 INCORRECT PRODUCT ADMINISTRATION DURATION 1
357 INCORRECT PRODUCT STORAGE 1
358 INFERTILITY FEMALE 1
359 INFLAMMATION 1
360 INFLUENZA 1
361 INFLUENZA LIKE ILLNESS 1
362 INJECTION SITE ABSCESS 1
363 INJECTION SITE ECZEMA 1
364 INJECTION SITE HYPOAESTHESIA 1
365 INJECTION SITE PAPULE 1
366 INJECTION SITE SCAR 1
367 INJURY 1
368 INTENTIONAL DEVICE USE ISSUE 1
369 INTENTIONAL PRODUCT MISUSE 1
370 INTERMENSTRUAL BLEEDING 1
371 INTRAOCULAR PRESSURE INCREASED 1
372 KNEE ARTHROPLASTY 1
373 LABORATORY TEST ABNORMAL 1
374 LACTOSE INTOLERANCE 1
375 LEIOMYOMA 1
376 LETHARGY 1
377 LEUKAEMIA 1
378 LIMB DISCOMFORT 1
379 LIP BLISTER 1
380 LIP DRY 1
381 LIPOEDEMA 1
382 LIVER INJURY 1
383 LOCALISED INFECTION 1
384 LOOSE TOOTH 1
385 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
386 LOWER LIMB FRACTURE 1
387 MASTITIS 1
388 MEDICATION ERROR 1
389 MENORRHAGIA 1
390 MESENTERIC VEIN THROMBOSIS 1
391 METRORRHAGIA 1
392 MORNING SICKNESS 1
393 MUSCLE DISORDER 1
394 MUSCLE HAEMORRHAGE 1
395 MUSCLE TIGHTNESS 1
396 MUSCULOSKELETAL CHEST PAIN 1
397 MUSCULOSKELETAL PAIN 1
398 MUSCULOSKELETAL STIFFNESS 1
399 MYOCARDIAL INFARCTION 1
400 NAIL DISORDER 1
401 NASOPHARYNGITIS 1
402 NECROSIS 1
403 NERVOUSNESS 1
404 NIPPLE ENLARGEMENT 1
405 NODULE 1
406 NON-CARDIOGENIC PULMONARY OEDEMA 1
407 OESOPHAGITIS 1
408 OPTIC NEUROPATHY 1
409 ORAL HERPES 1
410 OROPHARYNGEAL DISCOMFORT 1
411 OROPHARYNGEAL PAIN 1
412 ORTHOSTATIC HYPOTENSION 1
413 OVARIAN CYST RUPTURED 1
414 OVARIAN ENLARGEMENT 1
415 OVARIAN FAILURE 1
416 OVARIAN NECROSIS 1
417 OVARIAN TORSION 1
418 OVULATION INDUCTION 1
419 PAIN IN EXTREMITY 1
420 PAIN OF SKIN 1
421 PALLOR 1
422 PARAESTHESIA ORAL 1
423 PARANOIA 1
424 PELVIC ADHESIONS 1
425 PELVIC DISCOMFORT 1
426 PELVIC FLUID COLLECTION 1
427 PEMPHIGOID 1
428 PERIPHERAL COLDNESS 1
429 PLATELET COUNT INCREASED 1
430 PNEUMOTHORAX 1
431 POLLAKIURIA 1
432 POLYCYSTIC OVARIES 1
433 POOR PERIPHERAL CIRCULATION 1
434 POOR QUALITY DRUG ADMINISTERED 1
435 POOR RESPONSE TO OVULATION INDUCTION 1
436 PREGNANCY TEST FALSE POSITIVE 1
437 PREMATURE BABY 1
438 PREMATURE OVULATION 1
439 PRESCRIBED OVERDOSE 1
440 PRESCRIBED UNDERDOSE 1
441 PRODUCT COMMUNICATION ISSUE 1
442 PRODUCT CONTAMINATION 1
443 PRODUCT LOT NUMBER ISSUE 1
444 PRODUCT PREPARATION ISSUE 1
445 PRODUCT TAMPERING 1
446 PRODUCT USE COMPLAINT 1
447 PROGESTERONE DECREASED 1
448 PROGESTERONE INCREASED 1
449 PROTEIN DEFICIENCY 1
450 PROTEIN TOTAL DECREASED 1
451 PROTHROMBIN TIME PROLONGED 1
452 RASH MACULAR 1
453 RASH PAPULAR 1
454 RENAL FAILURE 1
455 RESPIRATORY TRACT INFECTION 1
456 RESTLESS LEGS SYNDROME 1
457 RHINORRHOEA 1
458 RUBBER SENSITIVITY 1
459 SALPINGITIS 1
460 SCAB 1
461 SCAR 1
462 SEIZURE 1
463 SEPSIS NEONATAL 1
464 SINUS CONGESTION 1
465 SKIN DISORDER 1
466 SKIN EXFOLIATION 1
467 SKIN TIGHTNESS 1
468 SLEEP APNOEA SYNDROME 1
469 SLEEP DISORDER 1
470 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
471 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1
472 SLEEP TALKING 1
473 SMALL FOR DATES BABY 1
474 STAPHYLOCOCCAL INFECTION 1
475 STILLBIRTH 1
476 SURGERY 1
477 SUSPECTED COUNTERFEIT PRODUCT 1
478 SYRINGE ISSUE 1
479 TENDERNESS 1
480 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
481 THERAPEUTIC RESPONSE CHANGED 1
482 THIRST 1
483 THREATENED LABOUR 1
484 THYROID NEOPLASM 1
485 TOOTH EXTRACTION 1
486 TUBO-OVARIAN ABSCESS 1
487 TYPE 1 DIABETES MELLITUS 1
488 ULTRASOUND SCAN VAGINA ABNORMAL 1
489 UNEVALUABLE EVENT 1
490 URINARY TRACT INFECTION 1
491 UTERINE HYPERSTIMULATION 1
492 VACTERL SYNDROME 1
493 VAGINAL ODOUR 1
494 VERTIGO 1
495 VULVOVAGINAL ERYTHEMA 1
496 VULVOVAGINAL PRURITUS 1
497 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1